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Nickel compounds are established human
carcinogens according to International
Agency for Research on Cancer (1). They are
widely distributed in modern industries.
Several industrial processes, e.g., nickel min-
ing and refining, electroplating, the produc-
tion of long-lasting nickel-cadmium batteries,
the combustion of fossil fuels, and the incin-
eration of nickel-containing solid waste, are
responsible for the production of nickel-
containing aerosols in the workplace and in
the surrounding environments.
Because of the widespread use of these
agents, workers in these facilities are at risk for
occupational exposure. In addition, the release
of nickel into the environment represents a
potential risk for nonoccupational exposure.
The average daily exposure to nickel by
inhalation has been estimated to be 0.2 and
0.4 µg for rural and urban dwellers, respec-
tively (2,3). Welders working with stainless
steel are another professional group with an
elevated risk for nickel-related carcinogenesis.
Inhalation is the main route for human
exposure to nickel compounds, and epidemio-
logic studies have demonstrated a correlation
between the incidence of respiratory (lung and
nasal) cancer and worksite exposure to nickel.
The inhalation of nickel-containing dusts and
aerosols poses the major hazard present in
nickel mines and reﬁneries. The main target
areas are those in the respiratory system,
depending on the size of nickel-containing
dust particles. The coarsest particles are
deposited in the nose, mouth, and larynx,
whereas the finer grains can reach the
bronchial tree (4,5).
The relative carcinogenic activity of nickel
compounds is related to their water solubility
(6). Water-soluble nickel salts (NiCl2, NiSO4)
are considered less carcinogenic than water-
insoluble compounds, such as NiS, Ni3S2,
and NiO, because the uptake of soluble nickel
compounds is poor. The soluble nickel com-
pounds dissolve in the mucus covering the air-
ways, and the resulting ionic or complexed
nickel is removed by the ciliary transport
mechanism. The potent carcinogenic activity
exhibited by crystalline nickel is due to the
ability of the Ni3S2 particles to enter cancer
target cells by phagocytosis (7).
Phagocytosis of particles, by either
macrophages or epithelial cells, causes buildup
of very high levels of nickel inside the cells after
its intracellular slow dissolution (Ni3S2 is dis-
solved by oxidation), catalyzed by the acidic
pH of endocytic vacuoles. A continuous source
of Ni(II) ions is provided in this manner.
Eventually the cells undergo neoplastic trans-
formation, and cancer develops in a process
that may take many years. The carcinogenic
potency of nickel compounds is consistently
related to the ability of Ni(II) to access
chromatin and cause multiple types of cellular-
nuclear damage via direct or indirect mecha-
nisms, including a) promutagenic DNA
damage, that is, oxidative damage to nucle-
obases as well as DNA strand breaks (8,9); b)
impairment of DNA repair mechanisms by
nickel (10,11); and c) epigenetic effects in chro-
matin, such as chromatin condensation and
inhibition of histone H4 acetylation (12–15).
Depending on the condition, it is possi-
ble that dual mechanisms, both genotoxic
(initiation) and epigenetic (promotion and
progression), can be operating (16). To
understand how damage affects different
nuclear components, we need to consider
briefly the structure of the cell nucleus. The
most fundamental building block of the cell
nucleus is called the nucleosome. It is com-
posed of an octameric assembly of proteins
called the core histones. The core histone
proteins and the nucleosomes they form with
DNA constitute the eukaryotic chromatin.
The core histone proteins (H3, H4, H2A,
and H2B), together with the linker histone
H1, package eukaryotic DNA into repeating
nucleosomal units that are folded into higher-
order chromatin ﬁbers. Once considered sta-
tic nonparticipating structural elements, it is
now clear that histones are integral and
dynamic components of the machinery
responsible for regulating gene transcription.
DNA is held on the surface of the protein
assembly by a trace of positively charged Arg
and Lys side chains and also by whiskers of
extended N-termini of histones (17). Histone
N-terminal tails are central to the processes
that modulate nucleosome structure and func-
tion. An extensive literature documents an
elaborate collection of posttranslational modi-
ﬁcations, including acetylation, that take place
on the N-terminal tail domains of histones.
Of these modifications, acetylation and
deacetylation have generated much interest
because gene activity is correlated with histone
acetylation (18).
Acetylation is an energy-intensive,
dynamic phenomenon, of which the steady-
state balance is mediated by the opposing
activities of histone acetyltransferase and
deacetylase enzyme systems. The acetylation
reaction involves the transfer of an acetyl
group from acetyl-coenzyme A onto the
amino group of specific lysine residues pre-
sent in the amino-terminal tails of each of the
core histones, resulting in the neutralization
of a single positive charge (19).
The continued interest in acetylation-
related phenomena undoubtedly stems from
the fact that the core histones are among the
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most conserved protein in eukaryotes, and the
specific lysines that undergo acetylation are
absolutely conserved in most cases. This
implies that the N-termini do not function
simply by interacting nonspeciﬁcally with the
DNA components of chromatin, because such
a mechanism would not require such an extra-
ordinary degree of sequence conservation.
N-termini are engaged primarily in
protein–protein interactions, which cause N-
termini to adopt speciﬁc secondary structure,
and recent evidence suggests that the function
of acetylation may be to disrupt these sec-
ondary structure motifs (19,20). Long-stand-
ing models have suggested that histone
acetylation may alter chromatin structure by
inﬂuencing histone–DNA, histone–histone,
and intranucleosome contacts; converging
biochemical and genetic evidence suggests
functions in several chromatin-based
processes. This may allow the termini to be
displaced from the nucleosome, causing the
nucleosome to unfold, and increasing access
to transcription factors (21,22). It could cause
an opening of these particles, increasing the
accessibility of DNA for regulatory factors, and
could provide a mechanism for the establish-
ment of an open, active chromatin structure.
This does not exclude an additional role for
histone tails in chromatin ﬁber compaction. 
A more recent hypothesis proposes that a
histone language (read by other proteins or
protein modules) may be encoded on these tail
domains. Covalent modiﬁcation like histone
acetylation could provide such a histone code
showing that every amino acid in histone tails
has speciﬁc meaning and is part of the vocabu-
lary of the overall code (23). This suggests that
any alteration in tail structure could be crucial.
These tails, which protrude from the surface of
the chromatin polymer and are protease sensi-
tive, comprise about 25–30% of the mass of
individual histones, thus providing an exposed
surface for potential interactions.
Although the molecular mechanisms
involved in nickel toxicity and carcinogenicity
are not fully understood, several studies
demonstrate that binding of nickel inside the
cells is the factor leading to all the cellular
pathways hypothesized to explain nickel
activity. Numerous studies point to the cell
nucleus as the site of nickel attack (12–14),
thus, the identification of cellular-nuclear
binding sites for nickel and the basic chemical
activities resulting from the binding modes
are objectives essential to understanding the
mechanisms involved. 
Following this line, DNA polymers bind
Ni(II) only weakly in vitro (24). The binding
of Ni(III) to DNA is ionic and involves phos-
phate oxygens. Such Ni(II) can be easily dis-
placed by other divalent cations, especially by
physiological DNA counterion Mg (II). In
addition, phospholipids of cellular membranes
do not provide high-afﬁnity binding sites for
Ni(II). This leaves the proteins and low-
molecular-weight chelators (e.g., amino acids
and peptides) as the most likely nickel-binding
molecules. Of all macromolecular components
of the cell nucleus except DNA itself, histones
are by far the most abundant among nuclear
proteins in somatic cells, reaching a formal
concentration of 3 mM (25). Therefore, by
the law of mass action, if Ni(II) binding sites
of even moderate affinity could be found in
the histones, they might be able to compete
for Ni(II) with higher affinity sites in other
but less-abundant nuclear proteins, or with
low-molecular-weight chelators. 
Indication for an existence of such a site
on core histones is provided by the fact that
nucleohistones largely enhance 8-oxo-7,8-
dihydro-2´-deoxyguanosine formation (the
major product of reactive oxygen species
attack in genomic DNA). In addition, unlike
pure DNA, exposure of chromatin (nucleohis-
tones) to ambient oxygen in the presence of
Ni(II) added as a noncomplexed salt also
results in an increased DNA base oxidation
(26). In fact Ni(II), especially in the form of
nickel complexed with certain natural ligands,
enhances the oxidation damage to DNA bases
(27). Thus, modulation of the damage by the
protein component of chromatin clearly indi-
cates complexation of nickel, most likely by
the histones. All these facts make nuclear
proteins the primary targets for Ni(II) ions. 
The detection and the structural and
mechanistic description of speciﬁc Ni(II) sites
in histones could provide a molecular basis
for better understanding the mechanisms
underlying Ni(II)-induced carcinogenesis.
This simple notion was the starting point for
our proposal to analyze and investigate his-
tones for Ni(II) binding. We reviewed the
published amino acid sequences of the his-
tones (28), as well as the structural data on
histone octamer, to identify possible Ni(II)
binding motifs and subsequently to investi-
gate the formation and properties of Ni(II)
complexes with those motifs.
Ni(II) is a borderline metal ion capable of
forming stable complexes with both hard
(oxygen) and soft (nitrogen, sulfur) donors.
Available information on the binding modes
of Ni(II) to proteins and data for nickel-
peptide complexes indicate, however, that
imidazole of histidine and thiol of cysteine
should be thermodynamically preferred by
Ni(II) among the donor groups provided by
protein-building amino acids (29,30).
Carboxyl groups of aspartate and glutamate
can play only secondary roles in binding.
There are two general modes of interaction of
transition metal ions, including Ni(II), with
peptides and proteins. The peptide mode
involves binding to the terminal groups and
deprotonated amide bonds of the peptide
backbone. It occurs in peptides containing
noncoordinating side chain in the amino ter-
minal residues. The protein mode uses only
the reactive side-chain groups; histidine imi-
dazole and cysteine thiol are most effective in
nickel binding. When histidine (or cysteine)
appears along the peptide chain, they facili-
tate peptide deprotonation by providing an
anchoring binding site for a metal ion. The
search for potential nickel-binding sites in the
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Figure 1. Sequences of predominant form of human histones. Histidine and cysteine residues are under-
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histones should therefore be focused on
terminal sequences histidine and cysteine.
Representative examples of the sequences
of predominant forms of human histones H1,
H2A and H2B, H3, and H4 are presented in
Figure 1 (9). As one can clearly see, the linker
histone H1 does not contain any His or Cys
residues, and contains only a few carboxylates.
Inspection of the available histone sequences
revealed several histidine and cysteine residues
in H2, H3, and H4. However, examination of
the X-ray crystal structure of the nucleosome
core particle reveals that histidine and cysteine
residues in H2 and H3 are located inside the
molecule in the protein interior. A histidine
(His18 from the N-terminal) can be seen in the
histone H4 N-terminal tail that extends from
the core, where it is accessible (and can be
posttranslationally modified by acetylation).
Histone H4 is one of the most conserved pro-
teins in nature, even for the amino terminal
region (residues 1–22, 23). This region fea-
tures three repetitions of the sequence
gly–lys–gly and the unusual string of ﬁve basic
residues -KRHRK- (Figure 2), which may
serve as a binding locus for selectively binding
nucleic acid. 
We found previously that nickel is a potent
inhibitor of histone H4 acetylation in yeast
and in mammalian cells (15). Interestingly, an
anchoring binding site for metal ions, a histi-
dine, is close to sites for posttranslational mod-
ification involved in nickel and, to a lesser
extent, in copper toxicity. 
All this information points to the H4 tail
as a candidate for an Ni(II) binding site in the
histone octamer. Because of its structural posi-
tion, this terminal part could be accessible for
metal binding. For this reason we analyzed,
for Ni(II) and Cu(II) binding, the sequence of
the N-terminal tail of the histone H4, the 22-
amino acid peptide Ac-SGRGKGGKGLG
KGGAKRHRKVL-Am. The C-terminus was
blocked by amidation to make the tail a more
relevant model of the entire protein. In addi-
tion, the 7- and 11-amino acid peptides
Ac-AK(Ac)RHRK(Ac)V-Am and Ac-
GK(Ac)GGAK(Ac)RHRK(Ac)V-Am, where
all side chains of lysines were blocked by
acetylation, were studied to verify whether the
acetylation of lysines affects coordination
behavior. The binding study was also
extended to Cu(II) to analyze if differences in
biological activity can result in differences in
coordination behavior.
Material and Methods
Potentiometric and Spectroscopic
Measurements
Stability constants for protons Ni(II) and
Cu(II) complexes were calculated from titration
curves carried out at 25°C using a total volume
of 1.5 cm3. NaOH was added from a 0.250
cm3 micrometer syringe calibrated by both
weight titration and the titration of standard
materials. Metal ion concentration was 1.5 ×
10–3 mol dm–3, and the metal-to-ligand molar
ratio was 1:1.1. pH meter titrations were per-
formed at 25°C in 0.10 mol dm–3 KNO3 on a
Molspin pH meter system (Molspin Ltd.,
Newcastle upon Tyne, UK) using a microcom-
bined glass/calomel electrode calibrated in
hydrogen ion concentrations using HNO3
(31). The SUPERQUAD computer program
(Superquad for the Calculations and Metal-
Complex Stability Constants, Version 5.2,
L.D. Pettit, Academic Software, Sourby Farm,
Timble Otley Yorks, UK) was used for stability
constant calculations (32). Standard deviations
quoted were computed by SUPERQUAD and
refer to random errors only. They are, how-
ever, a good indication of the importance of a
particular species in the equilibrium. 
It was not possible to perform the
potentiometric measurements for Ac-
GK(Ac)GGAK(Ac)RHRK(Ac)V-Am because
of the hydrolysis with raising the pH. In this
case only spectroscopic measurements were
carried out.
Solutions for spectroscopic measurements
were of similar concentrations to those used
in the potentiometric studies. Absorption
spectra were recorded on a Beckman DU 650
spectrophotometer Beckman Instruments
Inc., Fullerton, CA, USA). Circular dicro-
ism (CD) spectra were recorded on a
JASCO J 600 spectropolarimeter (JASCO,
Spectroscopic Co., Hiroshima, Japan) in the
750–250 nm range. The values of ∆ε (i.e.,
ε l–ε r) and ε were calculated at the maximum
concentration of the particular species
obtained from the potentiometric data.
Results and Discussion
The 22-amino acid sequence can be consid-
ered an H6L ligand, where the deprotonation
involves the histidine residue (pKa = 5.99)
and the ﬁve side chains of the lysine residues
(pKa = 11.79, 10.75, 10.08, 10.03, and
9.20). The 7- and 11-amino acid peptides
[Ac-AK(Ac)RHRK(Ac)V-Am and Ac-GKG-
GAK(Ac)RHRK(Ac)V-Am] are an HL lig-
and where the deprotonation involves the
histidine residue. 
The 22-amino acid peptide Ac-
SGRGKGGKGLGKGGAKRHRKVL-Am
binds Ni(II) and Cu(II) through the imida-
zole nitrogen, starting at pH 7 and at pH 3.5,
respectively, and resulting in 1N complexes.
When the pH was raised, both metal ions
deprotonated successive peptide nitrogens,
forming M–N– bonds, until MH2L species
(4N complexes) were formed above pH 8 for
Ni(II) and pH 6 for Cu(II). The formation of
the stable ﬁve-member chelate rings by con-
secutive nitrogens is the driving force for the
coordination process (Figure 3). 
The logK* value is a good measure of the
stability of the complex species, describing
competition of metal ions with protons for
peptide binding [logK* = logβ MHn–jL –
logβ HnL for the reaction M(II) + HnL ♦
MHn–jL + jH+]. The stability of the 4N
complex of Cu(II) with the 22-amino acid
peptide is higher (logK* = –21.79) compared
with that obtained for shorter fragments and
is comparable to that of 14-amino acid pep-
tide Ac-TRSRSHTSEGTRSR-Am, Cap43
(33). The stability of the 4N complex of
Ni(II) with the 22-amino acid peptide is
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Figure 2. AKRHRK sequence. The ribbon represents the backbone of the peptide.
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Figure 3. Scheme of the 4N-Ni(II) planar diamag-
netic species.higher (logK* = –28.67) or of similar stabil-
ity compared with that obtained for shorter
N- and C-blocked peptides containing the
histidine residue (34). Coordination behav-
ior was not significantly affected by the
acetylation of lysines.
The pKa values of N(3) imidazole nitro-
gen of the histidine residue of the tail and of
the models investigated are of the same order
of magnitude (ranging from 5.99 to 6.13).
They are more acidic than other simple pep-
tides, about one order of magnitude more
acidic than histidine in Boc-AGGH, Ac-
GGGH, and Ac-GGH (7.19, 7.21, and 7.18,
respectively), where glycine instead of argi-
nine or lysine residues are close to the anchor-
ing site for metal ions. It is interesting to note
that the pKa (NHim
+) values for our motifs
are of the same order of magnitude as that of
N-terminal free peptides and where electron-
withdrawing groups substitute a hydrogen at
the pyrrolic nitrogen (35). In this case the less
basicity is due both to the electrostatic effect
of the positive charge from NH3
+ terminus
and to the inductive effect of the substituting
group. In our case the minor basicity can be
associated with the electrostatic effect from
the positively charged side chains of R and K,
or R, in the peptide ligands. The log K* val-
ues for the formation at N(3) of imidazole
and of 1N complexes of acetylated peptides
are linearly related to the pKa (NHim
+) in the
free peptides (36).
It is to be expected that the labilizing
effect of the metal ions on the peptide pro-
tons will be strongly inﬂuenced by the extent
of electron donation by the group acting as
the initial coordination locus. Hence, a lower
pKa (NHim
+) value will be associated with a
lower degree of electron donation to the
metal ion, which will be reﬂected in a lower
value for pKa amide. Therefore, the lower the
basicity of the N(3), the more simple the
deprotonation, promoted by metal ions, of
amide nitrogens, resulting in an enhancement
of π -electron contribution to the metal amide
nitrogen bond compared with Boc-AGGH or
other simple peptides (37).
Ultraviolet-visible (UV-Vis) spectra are in
agreement with the results from potentiomet-
ric measurements. Figure 4 shows the UV-Vis
spectrum, obtained with changing the pH,
for the mixture of Ni(II) ions with the Ac-
GK(Ac)GGAK(Ac)RHRK(Ac)V-Am frag-
ment. The λ max value at 439 nm (ε = 104
dm3 mol–1cm–1) with a shoulder at 494 nmis
characteristic of a planar coordination of
Ni(II) ions in a 4N chromophore (38).
The impact of the secondary peptide
structure on the complex stability cannot be
excluded (39). The CD spectra of the fully
protonated and deprotonated form of the
tail are qualitatively the same, resembling
those of unordered peptides. It is interesting
to note that on coordination of the tail in a
4N complex with Ni(II), unlike motifs with
protected lysines and unlike Cu(II), there
was a change in the spectrum with a value
of ∆ε  about 5 mol cm–1dm–3 in the region
(220–230 nm) dominated by the peptide
carbonyl chromophore (spectrum not
shown). This behavior suggests a possible
bent structure with organized side-chain
orientation promoted by Ni(II)(39). 
Although the complexation with Ni(II) at
a physiological pH under our experimental
conditions is not very effective, the formation
of a rigid square-planar complex may result,
somewhat paradoxically, in a higher speci-
ﬁcity of Ni(II) to produce a particular confor-
mation of the peptide (40). The presence of
positively charged residues close to the metal-
binding site in the H4 tail can result in a site-
selectivity association of the Ni(II) complexed
tail with the negatively charged DNA back-
bone (41). In addition the hydrophobic envi-
ronment in the entire protein is expected to
enhance metal-binding capabilities because of
multiple nonbonding interactions available
there, as reported in the literature (42–44).
In conclusion histidine-18 residue can
be a primary binding site for Ni(II) ions in
the H4 tail. The coordination ability of the
entire tail toward Ni(II) is similar to that
found for the hexapeptide fragment
AKRHRK (45), but the conformation
behavior is dependent on the chain length
and on the metal ion. In fact, Ni(II) coordi-
nation to the 22-amino acid peptide
induces organized side-chain orientation
unlike Cu(II) and unlike motifs with pro-
tected lysines. The data obtained with
Ni(II) and Cu(II) metal ions point out an
interesting aspect, as they seem to show that
the sequence of the H4 amino-terminal tail
can adopt different conformations, depend-
ing on the metal ion. All these facts may be
physiologically relevant to the mechanism
of nickel-induced carcinogenicity. 
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